February 20, 2024
Ono Pharmaceutical said on February 19 that it has concluded a research collaboration deal with InveniAI aiming to find novel therapeutic targets by drawing on the US firm’s artificial intelligence and machine learning technologies. Under the deal, InveniAI will identify...read more